My watch list
my.bionity.com  
Login  

Trial Drugs for Treatment of the Ebola Virus

13-Jun-2016

© Compound Interest

Trial Drugs for Treatment of the Ebola Virus

The current ebola virus epidemic in West Africa has dominated the news in recent months, and in the past week, several medical organisations have announced their intention to commence trials with possible treatments for the virus in the coming months. Two of these treatments are the anti-viral drugs brincidofovir and favipiravir, chosen due to some promising data on their potential efficacy against the virus, as well as their non-prohibitive costs. Here, we take a look at them in a little more detail.

Topics
  • single-strand RNA viruses
  • brincidofovir
  • favipiravir
More about Compound Interest
  • Infographics

    2018’s biggest science stories

    As we head into 2019, it’s time to take a look back at some of the biggest science news stories over the past year. This year’s science news featured water on Mars, the effects of e-cigarettes, new types of isomerism and bonding, and more! 2018 saw a number of significant discoveries in sci ... more

    Unleashing our immune systems against cancer

    The first of the 2018 Nobel Prizes is awarded. The 2018 Nobel Prize in Physiology or Medicine was awarded to James P. Allison and Tasuku Honjo for their discovery of cancer therapy by stimulating the immune system to attack tumour cells. This graphic takes a look at the prize-winning research. more

    The creation of tools made from laser light

    After the Nobel Prize for Physiology or Medicine has been awarded, it is physics' turn. The 2018 Nobel Prize in Physics was awarded to Arthur Ashkin, Gérard Morou and Donna Strickland for their pioneering innovations in the field of laser physics. Strickland is only the third woman to recei ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE